Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2025 Earnings Call Transcript May 1, 2025
Phathom Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.31 EPS, expectations were $-1.06.
Operator: Hello and welcome to the Phathom Pharmaceuticals’ First Quarter 2025 Earnings Results Call. [Operator Instructions] Please be advised that today’s conference is being recorded. With that, I would like to turn the conference over to Eric Sciorilli, Phathom’s Head of Investor...
